Neuromyelitis optica spectrum disorder: do patients positive and negative for anti¿aquaporin-4 antibodies present distinct entities? A Colombian perspective P.A. Ortiz Salas; M. Gaviria Carrillo; G.A. Cortés Bernal; K. Moreno Medina; L.F. Roa; J.H. Rodríguez Quintana;

Should tocilizumab be the first line treatment for neuromyelitis optica together with rituximab? R. Sawaya; G. Saab; H. Moussa;

Healthcare impact of electroencephalography performed during clinical neurophysiology on-call duty in a third-level hospital F. Vázquez-Sánchez; M.C. Lloria-Gil; B. García-López; O. Pérez-Gil; A. Saponaro-González; E. Rivas-Navas; A.I. Gómez-Menéndez;